CCDC39 Gene Primary ciliary dyskinesia type 14 Genetic Test
Test Name: CCDC39 Gene Primary ciliary dyskinesia type 14 Genetic Test
Components: Blood or Extracted DNA or One drop Blood on FTA Card
Price: 4400.0 AED
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test type: Ear Nose Throat Disorders
Doctor: ENT Doctor
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for SLC52A2 Gene Brown-Vialetto-Van Laere syndrome type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SLC52A2 Gene Brown-Vialetto-Van Laere syndrome type 2 NGS Genetic DNA Test gene SLC52A17
Test Details
The CCDC39 gene is associated with a genetic disorder called primary ciliary dyskinesia type 14 (PCD14). PCD14 is a rare inherited condition that affects the function of cilia, which are tiny hair-like structures found on the surface of cells in the respiratory tract, fallopian tubes, and other organs. Cilia play a crucial role in moving mucus, bacteria, and other substances out of the respiratory tract and other organs. In individuals with PCD14, mutations in the CCDC39 gene lead to abnormal ciliary function, resulting in a build-up of mucus and impaired clearance of particles from the airways.
NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze a person’s DNA for specific genetic mutations or variations. In the context of PCD14, NGS genetic testing can be used to identify mutations in the CCDC39 gene that may be causing the condition. This type of testing can help confirm a diagnosis, guide treatment decisions, and provide information about the inheritance pattern of the condition.
It is important to note that genetic testing for PCD14 and other genetic disorders should be conducted by a qualified healthcare professional or genetic counselor who can interpret the results and provide appropriate guidance and support.
| Test Name | CCDC39 Gene Primary ciliary dyskinesia type 14 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Ear Nose Throat Disorders |
| Doctor | ENT Doctor |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for SLC52A2 Gene Brown-Vialetto-Van Laere syndrome type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SLC52A2 Gene Brown-Vialetto-Van Laere syndrome type 2 NGS Genetic DNA Test gene SLC52A17 |
| Test Details |
The CCDC39 gene is associated with a genetic disorder called primary ciliary dyskinesia type 14 (PCD14). PCD14 is a rare inherited condition that affects the function of cilia, which are tiny hair-like structures found on the surface of cells in the respiratory tract, fallopian tubes, and other organs. Cilia play a crucial role in moving mucus, bacteria, and other substances out of the respiratory tract and other organs. In individuals with PCD14, mutations in the CCDC39 gene lead to abnormal ciliary function, resulting in a build-up of mucus and impaired clearance of particles from the airways. NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze a person’s DNA for specific genetic mutations or variations. In the context of PCD14, NGS genetic testing can be used to identify mutations in the CCDC39 gene that may be causing the condition. This type of testing can help confirm a diagnosis, guide treatment decisions, and provide information about the inheritance pattern of the condition. It is important to note that genetic testing for PCD14 and other genetic disorders should be conducted by a qualified healthcare professional or genetic counselor who can interpret the results and provide appropriate guidance and support. |
